FDA Conditionally Approves First Oral Tablet to Treat Chemotherapy-Induced Diarrhea in Dogs

For immediate release: December 21, 2021 Today the US Food and Drug Administration conditionally approved Canalevia-CA1 (Crofelemer sustained-release tablets) for the treatment of chemotherapy-induced diarrhea in dogs. This is the…

Jaguar Health Completes Filing of New Animal Drug Application for Conditional Approval of Canalevia-CA1 (Crofelemer) to Treat Chemotherapy-Induced Diarrhea in Dogs, Clearing Way for December 2021 Launch

Canalevia ™ -CA1 is the first and only oral prescription herbal drug candidate for CID in dogsJaguar launches awareness-raising competition in honor of International Jaguar Day; click here enter SAN…

Jaguar Well being Gives Updates on Canalevia (Crofelemer), the First Plant-based Prescription Drugs Underneath Improvement for Chemotherapy-induced Diarrhea in Canines and Train-induced Diarrhea in Canines

Step onto Wall Street with StreetInsider Premium. Request your 1-week free trial here. Canalevia would be the first and only FDA-approved herbal medicine for dogs suffering from diarrhea while on…

Jaguar Well being Supplies Updates on Canalevia (Crofelemer), the First Plant-based Prescription Drugs Underneath Growth for Chemotherapy-induced Diarrhea in Canines and Train-induced Diarrhea in Canines

Canalevia would be the first and only FDA-approved herbal medicine for dogs suffering from diarrhea while on chemotherapy Canalevia will be available through the fourth quarter of 2021, subject to…